Spero Therapeutics (SPRO)
(Delayed Data from NSDQ)
$1.07 USD
+0.17 (19.38%)
Updated Aug 17, 2022 04:00 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/09/2022
Time: -- |
9/2022 | $-0.26 | 0.00% |
Earnings Summary
For their last quarter, Spero Therapeutics (SPRO) reported earnings of -$0.87 per share, beating the Zacks Consensus Estimate of $-0.88 per share. This reflects a positive earnings surprise of 1.14%. Look out for SPRO's next earnings release expected on November 09, 2022. For the next earning release, we expect the company to report earnings of -$0.26 per share, reflecting a year-over-year increase of 62.86%.
Earnings History
Price & Consensus
Zacks News for SPRO
Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Lags Revenue Estimates
SPRO: What are Zacks experts saying now?
Zacks Private Portfolio Services